Nucala 100MG/ML 1ML 1S
Ended Awarded
- Contract number
- SPE2DR26FBTCM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,523
Award facts
- Contract value 100% obligated
- $13,522.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,522.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100mg/ml injectable medication. Issued on November 5, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement with an ultimate completion date of November 6, 2025. The award utilizes no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The company will supply the product to be distributed through federal healthcare channels, with performance centered at its Park Ridge, Illinois headquarters.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy supporting Department of Defense healthcare operations worldwide. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499.999 billion with a completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. As one of multiple regional prime vendor contractors under this program, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity supplying an extensive portfolio of branded and generic pharmaceuticals, biologics, vaccines, and specialty medical products to support military healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DR26FBTCM?
SPE2DR26FBTCM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FBTCM worth?
The government has obligated $13,523 on SPE2DR26FBTCM.
Is contract SPE2DR26FBTCM an order under another contract?
Yes. SPE2DR26FBTCM is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTCM competed?
The extent of competition for SPE2DR26FBTCM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award